Therapies for shoulder dysfunction after breast cancer-related lymphedema
Scapular Proprioceptive Neuromuscular Facilitation and Activity Oriented Antiedema Proprioceptive Therapy on Shoulder Dysfunction Post Matectomy Lymphedema
This study is testing different therapy combinations to see if they can help women with shoulder problems caused by lymphedema after breast cancer treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 93 (estimated) |
| Ages | 40 Years to 60 Years |
| Sex | Female |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06602180 on ClinicalTrials.gov |
What this trial studies
This study involves ninety-three female patients experiencing shoulder dysfunction due to breast cancer-related arm lymphedema. Participants will be randomly assigned to one of three groups, each receiving different combinations of scapular proprioceptive neuromuscular facilitation (PNF) techniques, activity-oriented antiedema proprioceptive therapy (TAPA), and conventional physiotherapy through complex decongestive therapy (CDT). The aim is to evaluate the effectiveness of these therapeutic approaches in alleviating shoulder dysfunction and reducing edema.
Who should consider this trial
Good fit: Ideal candidates are female patients aged 40-60 with unilateral breast cancer and shoulder dysfunction due to lymphedema.
Not a fit: Patients with bilateral lymphedema, active infections, or other significant health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve shoulder function and reduce lymphedema symptoms in women post-mastectomy.
How similar studies have performed: While similar therapeutic approaches have been explored, this specific combination of interventions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The subject selection will be according to the following criteria: * Age range between 40-60 years. * Only female patients will participate in the study. * All female patients diagnosed as unilateral breast cancer. * All Female patients operated on for BC with BCRL in stages I and II. * All female patients suffering from shoulder dysfunction after breast cancer-related arm lymphedema. * All patients enrolled to the study will have their informed consent. Exclusion Criteria: The potential participants will be excluded if they meet one of the following criteria: * Patients with health problems, diseases or dysfunctions that prevented them from participating in the intervention. * Patients with bilateral lymphedema. * Patients with previous primary lymphedema. * Patients with metastasis. * Patients whom staging was not possible due to atypical findings or poor image. * Patients with active arm infection.
Where this trial is running
Cairo
- Faculty of Physical Therapy — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: rasha ahmed, master — Cairo University
- Study coordinator: rasha ahmed, master
- Email: rashaphysio2018@gmail.com
- Phone: 01018077831
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.